ABOUT THE RESULTS OF INNOVATIVE PHARMACOTHERAPY IN ONCOLOGY
Journal: Science Journal "NovaInfo" (Vol.1, No. 59)Publication Date: 2017-02-14
Authors : Bezmelnitsyna Lyudmila Yurevna; Berseneva Evgeniya Aleksandrovna; Isaeva Anastasiya Vitalevna; Meshkov Dmitriy Olegovich; Spasennikov Boris Aristarkhovich; Khabriev Ramil Usmanovich; Cherkasov Sergey Nikolaevich;
Page : 450-456
Keywords : PHARMACEUTICALS; INNOVATION; AZACITIDINE; BENDAMUSTINE; PEMETREXED; HEALTHCARE; CLINICAL AND ECONOMIC ANALYSIS; CANCER PATHOLOGY; MORTALITY;
Abstract
The decrease of mortality rates of oncology patients correlates with the number of innovative medications available in the market. Integrated approach based on population health monitoring, innovative technologies development forecast and health technology assessment would make possible to overcome barriers preventing achieving accessibility of health interventions which and access to medical care.
Other Latest Articles
- DIAGNOSIS OF CURRENT ASSETS LIQUIDITY AND SOLVENCY OF PAO "MMC" NORILSK NICKEL"
- THE LEVEL OF PHYSICAL DEVELOPMENT OF PRIMARY SCHOOL-AGE CHILDREN WITH VISUAL IMPAIRMENT
- NEUROPLASTICITY AS A BASIS OF RECOVERY AFTER STROKE AND MOBILITY TRAINING IN TREATING AFTER-STROKE PATIENTS
- THE TECHNOLOGY OF MANUFACTURE OF THE WORKING BODIES OF CHOPPER MEAT PRODUCTS
- USING OF MODERN FLOAT UNIT TO RAFTING WOOD ON SHALLOW DEPTHS RIVERS
Last modified: 2017-09-20 17:35:45